Canlyniadau Chwilio - Takuji Okusaka

Mireinio'r Canlyniadau
  1. 1
    Immunotherapy for hepatocellular carcinoma: current status and future perspectives

    Immunotherapy for hepatocellular carcinoma: current status and future perspectives gan Takuji Okusaka, Masafumi Ikeda

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines

    Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines gan Takuji Okusaka, Junji Furuse

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Phase II study of S-1 in patients with advanced biliary tract cancer

    Phase II study of S-1 in patients with advanced biliary tract cancer gan Hideki Ueno, Takuji Okusaka, Masafumi Ikeda, Yoriko Takezako, Chigusa Morizane

    Cyhoeddwyd 2004
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    A National Survey to Systematically Identify Factors Associated With Oncologists’ Attitudes Toward End-of-Life Discussions: What Determines Timing of End-of-Life Discussions?

    A National Survey to Systematically Identify Factors Associated With Oncologists’ Attitudes Toward End-of-Life Discussions: What Determines Timing of End-of-Life Discussions? gan Masanori Mori, Chikako Shimizu, Asao Ogawa, Takuji Okusaka, Saran Yoshida, Tatsuya Morita

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Chemotherapy for hepatocellular carcinoma: current status and future perspectives

    Chemotherapy for hepatocellular carcinoma: current status and future perspectives gan Masafumi Ikeda, Chigusa Morizane, Makoto Ueno, Takuji Okusaka, Hiroshi Ishii, Junji Furuse

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    New developments in systemic therapy for advanced biliary tract cancer

    New developments in systemic therapy for advanced biliary tract cancer gan Chigusa Morizane, Makoto Ueno, Masafumi Ikeda, Takuji Okusaka, Hiroshi Ishii, Junji Furuse

    Cyhoeddwyd 2018
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT)

    Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT) gan Junki Mizusawa, Chigusa Morizane, Takuji Okusaka, Hiroshi Katayama, Hiroshi Ishii, Haruhiko Fukuda, Junji Furuse

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure-Response Analyses

    Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure-Response Analyses gan Toshiyuki Tamai, Seiichi Hayato, Seiichiro Hojo, Takuya Suzuki, Takuji Okusaka, Kenji Ikeda, Hiromitsu Kumada

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma

    Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma gan Shunsuke Kondo, Hideki Ueno, Hiroko Hosoi, Junichiro Hashimoto, Chigusa Morizane, Fumiaki Koizumi, Kenji Tamura, Takuji Okusaka

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Phase <scp>II</scp> study of <scp>FOLFIRINOX</scp> for chemotherapy‐naïve Japanese patients with metastatic pancreatic cancer

    Phase <scp>II</scp> study of <scp>FOLFIRINOX</scp> for chemotherapy‐naïve Japanese patients with metastatic pancreatic cancer gan Takuji Okusaka, Masafumi Ikeda, Akira Fukutomi, Tatsuya Ioka, Junji Furuse, Shinichi Ohkawa, Hiroyuki Isayama, Narikazu Boku

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Elevated Serum Interleukin-6 Levels in Patients with Pancreatic Cancer

    Elevated Serum Interleukin-6 Levels in Patients with Pancreatic Cancer gan Shoichi Okada, Takuji Okusaka, Hiroshi Ishii, Akiko Kyogoku, Masayoshi Yoshimori, Naoko Kajimura, Ken Yamaguchi, Tadao Kakizoe

    Cyhoeddwyd 1998
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Systemic Chemotherapy for Advanced Hepatocellular Carcinoma: Past, Present, and Future

    Systemic Chemotherapy for Advanced Hepatocellular Carcinoma: Past, Present, and Future gan Masafumi Ikeda, Shuichi Mitsunaga, Izumi Ohno, Yusuke Hashimoto, Hideaki Takahashi, Kazuo Watanabe, Kumiko Umemoto, Takuji Okusaka

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer

    Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer gan Takuji Okusaka, Yukako Ιtο, Hideki Ueno, Masafumi Ikeda, Yoriko Takezako, Chigusa Morizane, Yoshikazu Kagami, Hiroshi Ikeda

    Cyhoeddwyd 2004
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Japanese phase I study of<scp>GC</scp>33, a humanized antibody against glypican‐3 for advanced hepatocellular carcinoma

    Japanese phase I study of<scp>GC</scp>33, a humanized antibody against glypican‐3 for advanced hepatocellular carcinoma gan Masafumi Ikeda, Shinichi Ohkawa, Takuji Okusaka, Shuichi Mitsunaga, Satoshi Kobayashi, Chigusa Morizane, Ikue Suzuki, S. Yamamoto, Junji Furuse

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials

    Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials gan Juan W. Valle, Junji Furuse, Mark Jitlal, Sandy Beare, Nobumasa Mizuno, Harpreet Wasan, John Bridgewater, Takuji Okusaka

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection

    Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection gan Hiroshi Ishii, Shuichi Okada, Haruhiko Nose, Takuji Okusaka, Masayoshi Yoshimori, Tadatoshi Takayama, T Kosuge, Susumu Yamasaki, Michiie Sakamoto, S Hirohashi

    Cyhoeddwyd 1996
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT)

    A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT) gan Kohei Nakachi, Masaru Konishi, Masafumi Ikeda, Junki Mizusawa, Junko Eba, Takuji Okusaka, Hiroshi Ishii, Haruhiko Fukuda, Junji Furuse

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Clinical Practice Guidelines for Pancreatic Cancer 2019 From the Japan Pancreas Society

    Clinical Practice Guidelines for Pancreatic Cancer 2019 From the Japan Pancreas Society gan Takuji Okusaka, Satoaki Nakamura, Masahiro Yoshida, Masayuki Kitano, Katsuhiko Uesaka, Yoshinori Ito, Junji Furuse, Keiji Hanada, Kazuichi Okazaki

    Cyhoeddwyd 2020
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Phase II Study of Gemcitabine Chemotherapy Alone for Locally Advanced Pancreatic Carcinoma: JCOG0506

    Phase II Study of Gemcitabine Chemotherapy Alone for Locally Advanced Pancreatic Carcinoma: JCOG0506 gan Hiroshi Ishii, J. Furuse, Narikazu Boku, Takuji Okusaka, Masafumi Ikeda, S. Ohkawa, Akira Fukutomi, Yasuo Hamamoto, K. Nakamura, Hiroyuki Fukuda

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Derived neutrophil lymphocyte ratio may predict benefit from cisplatin in the advanced biliary cancer: the ABC-02 and BT-22 studies

    Derived neutrophil lymphocyte ratio may predict benefit from cisplatin in the advanced biliary cancer: the ABC-02 and BT-22 studies gan Tal Grenader, Stephen Nash, Yevgeni Plotkin, Junji Furuse, Nobumasa Mizuno, Takuji Okusaka, Harpreet Wasan, Juan W. Valle, John Bridgewater

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: